Vitis vinifera L. Leaf Extract Inhibits In Vitro Mediators of Inflammation and Oxidative Stress Involved in Inflammatory-Based Skin Diseases

Psoriasis is a chronic cutaneous condition characterized by the release of pro-inflammatory mediators and oxidative stress. The reduction of these factors is currently the most effective strategy to inhibit the symptoms of pathology. Antioxidants from natural sources are increasingly used to improve skin conditions. Dried red leaves from grapevine (Vitis vinifera L., cv Teinturiers) showed anti-inflammatory and anti-bacterial activities, but their possible effects on keratinocytes have not been previously investigated. In this study we tested the ability of a water extract from grapevine leaves (VVWE) to inhibit inflammatory conditions in human keratinocytes (HaCaT cells), challenged with proinflammatory (tumor necrosis factor-α (TNF-α) or lipopolysaccharide (LPS)) or prooxidant (ultraviolet B radiation (UVB) or H2O2) mediators. VVWE inhibited interleukin-8 (IL-8) secretion induced by proinflammatory stimuli, acting on the IL-8 promoter activity, but the effect was lower when prooxidant mediators were used. The effect was partly explained by the reduction of nuclear factor-κB (NF-κB)-driven transcription and nuclear translocation. Furthermore, vascular endothelial growth factor (VEGF) secretion, a regulator of angiogenesis, was inhibited by VVWE, but not matrix metalloproteinase-9 (MMP-9), a protease involved in matrix remodeling. VVWE, assayed on Franz diffusion cell system, showed a marked reduction of High Performance Liquid Chromatography (HPLC)-identified compounds. Pure molecules individually failed to reduce TNF-α-induced IL-8 release, suggesting synergistic effects or the presence of other bioactive compounds still unknown.

[1]  F. Romeo,et al.  Bioactive compounds and antioxidant activity of four rose hip species from spontaneous Sicilian flora. , 2019, Food chemistry.

[2]  S. Piazza,et al.  In vitro evidences of the traditional use of Rhus coriaria L. fruits against skin inflammatory conditions. , 2019, Journal of ethnopharmacology.

[3]  A. Romani,et al.  In vitro studies on anti-inflammatory activities of kiwifruit peel extract in human THP-1 monocytes. , 2019, Journal of ethnopharmacology.

[4]  J. A. Ataide,et al.  In vitro antioxidant activity and solar protection factor of blackberry and raspberry extracts in topical formulation , 2018, Journal of cosmetic dermatology.

[5]  N. Lacetera,et al.  Anti-Inflammatory Effects of Pomegranate Peel Extracts on In Vitro Human Intestinal Caco-2 Cells and Ex Vivo Porcine Colonic Tissue Explants , 2019, Nutrients.

[6]  P. Minghetti,et al.  Emulsion versus nanoemulsion: how much is the formulative shift critical for a cosmetic product? , 2018, Drug Delivery and Translational Research.

[7]  M. Dell’Agli,et al.  HaCaT Cells as a Reliable In Vitro Differentiation Model to Dissect the Inflammatory/Repair Response of Human Keratinocytes , 2017, Mediators of inflammation.

[8]  Wei Wang,et al.  DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression , 2017, Journal of cancer metastasis and treatment.

[9]  T. Radhiga,et al.  Phytochemicals as modulators of ultraviolet-b radiation induced cellular and molecular events: A review , 2016 .

[10]  M. Dell’Agli,et al.  The effect of in vitro gastrointestinal digestion on the anti-inflammatory activity of Vitis vinifera L. leaves. , 2015, Food & function.

[11]  A. Zhang,et al.  Plant extracts for the topical management of psoriasis: a systematic review and meta‐analysis , 2013, The British journal of dermatology.

[12]  J. Pereira,et al.  Vitis vinifera leaves towards bioactivity , 2013 .

[13]  A. Offidani,et al.  Oxidative stress and psoriasis: the effect of antitumour necrosis factor‐α inhibitor treatment , 2013, The British journal of dermatology.

[14]  A. Gottlieb,et al.  NF-κB: an essential transcription factor in psoriasis. , 2013, Journal of dermatological science.

[15]  Liu Wei-na,et al.  Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. , 2012, International journal of pharmaceutics.

[16]  A. Knulst,et al.  Evaluation of the child with atopic dermatitis , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[17]  H. Norsgaard,et al.  Psoriasis drug discovery: methods for evaluation of potential drug candidates , 2012, Expert opinion on drug discovery.

[18]  M. Stücker,et al.  Efficacy and tolerability of a red-vine-leaf extract in patients suffering from chronic venous insufficiency--results of a double-blind placebo-controlled study. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[19]  M. Pasparakis,et al.  NF-κB in the regulation of epithelial homeostasis and inflammation , 2011, Cell Research.

[20]  J. Gelfand,et al.  Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literature. , 2009, Journal of the American Academy of Dermatology.

[21]  Frank O. Nestle,et al.  Skin immune sentinels in health and disease , 2009, Nature Reviews Immunology.

[22]  Frank O. Nestle,et al.  Mechanisms of Disease: Psoriasis. , 2009 .

[23]  Nilüfer Orhan,et al.  Biological Screening of Vitis vinifera L. Leaf Fractions , 2009 .

[24]  Nilüfer Orhan,et al.  Biological activities of Vitis vinifera L. leaves , 2009 .

[25]  M. Detmar,et al.  Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor. , 2008, The American journal of pathology.

[26]  E. Berardesca,et al.  Effective Therapy with Anti‐TNF‐α in Patients with Psoriatic Arthritis Is Associated with Decreased Levels of Metalloproteinases and Angiogenic Cytokines in the Sera and Skin Lesions , 2007, Annals of the New York Academy of Sciences.

[27]  Jae-We Cho,et al.  Curcumin attenuates the expression of IL-1β, IL-6, and TNF-α as well as cyclin E in TNF-α-treated HaCaT cells; NF-κB and MAPKs as potential upstream targets , 2007 .

[28]  Jae-We Cho,et al.  Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. , 2007, International journal of molecular medicine.

[29]  F. Nestle,et al.  Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial , 2005, The Lancet.

[30]  N. Scheinfeld A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab , 2004, The Journal of dermatological treatment.

[31]  A. Schrader,et al.  Transdermal delivery of two antioxidants from different cosmetic formulations , 2003, International journal of cosmetic science.

[32]  D. Sauder,et al.  Neovastat (AE-941), an inhibitor of angiogenesis: Randomized phase I/II clinical trial results in patients with plaque psoriasis. , 2002, Journal of the American Academy of Dermatology.

[33]  S. Rantapää Dahlqvist,et al.  Matrix metalloproteinase 9 (MMP-9) in patients with psoriatic arthritis and rheumatoid arthritis. , 2001, Clinical and experimental rheumatology.

[34]  E. Christophers Psoriasis − epidemiology and clinical spectrum , 2001, Clinical and experimental dermatology.

[35]  M. Diaz,et al.  Abnormal NF-kappaB signaling pathway with enhanced susceptibility to apoptosis in immortalized keratinocytes. , 2001, Journal of dermatological science.

[36]  B. Nickoloff Skin innate immune system in psoriasis: friend or foe? , 1999, The Journal of clinical investigation.

[37]  H. Dvorak,et al.  Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis , 1994, The Journal of experimental medicine.

[38]  E. Farber,et al.  The natural history of psoriasis in 5,600 patients. , 1974, Dermatologica.